Spots Global Cancer Trial Database for Digital Rectal Exam Proficiency Tool

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Digital Rectal Exam Proficiency Tool

Official Title: Validation of the DiRECT Proficiency Tool

Study ID: NCT02278679

Conditions

Prostatic Hyperplasia

Prostate Cancer

Interventions

Digital Rectal Exam

Study Description

Brief Summary: A digital rectal exam proficiency tool, titled the 'DiRECT' was developed based on the consensus of 10 experts. The purpose of this study is to validate this tool for use in both undergraduate and graduate medical education .

Detailed Description: First, it will be validated on 120 anesthetized patients undergoing prostate surgery, comparing responses on the digital rectal exam clinical tool (DiRECT) from both expert and novice clinicians, with surgical pathology reports. The second phase of validation will involve the participation of standardized patients, medical students and MUTA (medical urology teaching associate). During a standardized patient exercise focusing on digital rectal exam in the University of Virginia School of Medicine curriculum, 160 second-year medical students will be given the DiRECT to document their examination. An attending physician will also attend the standardized patient exercise and document their examination for comparison with the medical students. The third phase includes 8 residents and up to10 attendings in the Urology clinic, who will independently complete the DiRECT documenting their DRE in the course of usual care. Comparison of faculty and student/trainee responses in all phases will be used for validation of the clinical tool for further use in medical education.